Companies in #Immune Thrombocytopenia
Found 1 company operating in this sector.
Rigel Pharmaceuticals is a commercial-stage biotechnology company focused on hematologic disorders and cancer, marketing TAVALISSE (fostamatinib) for chronic immune thrombocytopenia, REZLIDHIA (olutasidenib) for relapsed or refractory AML with an IDH1 mutation, and GAVRETO (pralsetinib) for RET fusion-positive cancers.